ivonescimab
Commercial- Indications
- Non-small cell lung cancer, Biliary tract cancer, Triple-negative breast cancer, Head and neck squamous cell carcinoma
Company intelligence / Profile preview
Akeso Health Sciences has been providing science-backed natural dietary supplements for over two decades. Its flagship product line MigreLief offers patented nutritional solutions for migraine sufferers and has been widely adopted by patients and recommended by healthcare professionals. The company emphasizes rigorous quality control with third-party testing and clinical research backing its formulations. Chief Scientific Officer Curt Hendrix has led NIH-funded studies on the effects of these formulations in conditions such as Alzheimer’s disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Akeso Health Sciences.